Specifically: on one hand, EVs from obese individuals may carry miRNAs and other molecules that regulate insulin signaling, affecting the reduced sensitivity of target cells to insulin; on the other hand, these EVs may also affect the metabolic activities of the liver and adipocytes, thereby modulating insulin resistance and metabolic disorders. This evidence concerns the gene INS and metabolic disease.